Related Experiment Video

Updated: Mar 21, 2026

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.8K

Alterations in genes other than EGFR/ALK/ROS1 in non-small cell lung cancer: trials and treatment options

Arpita Desai1, Smitha P Menon2, Grace K Dy1

  • 1Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.

Cancer Biology & Medicine
|May 5, 2016
PubMed

Insights

Recent lung cancer therapy advances include targeted drugs for specific genetic mutations. This review covers treatments for MET, FGFR, NTRK, RET, HER2, HER3, HER4 alterations, and RAS-RAF-MEK pathway components.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Lung cancer therapy has significantly advanced in the past decade.
  • Identification of actionable mutations (e.g., EGFR) and translocations (e.g., ALK, ROS1) has enabled targeted therapies.
  • Oral targeted agents offer excellent tumor response and manageable side effects for specific patient subsets.

Purpose of the Study:

  • To review current and emerging treatment options for lung cancer.
  • To highlight clinical trials targeting specific oncogenic alterations.
  • To focus on receptor tyrosine kinases and RAS-RAF-MEK pathway components.

Main Methods:

  • Literature review of recent advancements in lung cancer therapy.
  • Analysis of clinical trials and targeted agents.
  • Focus on specific genetic alterations and signaling pathways.

Main Results:

  • Targeted therapies have shown significant efficacy in subsets of lung cancer patients.
  • Numerous oncogenic alterations are now targets for novel therapeutic strategies.
  • Ongoing clinical trials are expanding treatment options.

Conclusions:

  • Targeted therapies represent a major progress in lung cancer treatment.
  • Understanding oncogenic alterations is crucial for personalized medicine.
  • Further research and clinical trials are essential to improve patient outcomes.
Keywords:
MEKRAFRASfibroblast growth factor receptor (FGFR)non-small cell lung cance (NSCLC)receptor tyrosine kinases (RTK)

More Related Videos

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

505
Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

8.5K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
65
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.5K